Substitution K574A in gp41 decreases the thermostability of HIV-1 functional Env. by Daniel P. Leaman (105329)

Subjects:

A flow chart overview of the mixed ABM model as coded in NetLogo [57]. by Fijnanda van Klingeren (9316647)

Developmental regulation of the decrease in adhesion. by Marco Tarantola (102609)

Subjects:

Baseline characteristics of the study population. by Jesse J. Aarden (6919745)

Inclusion of participants in the study (N = 391). by Jesse J. Aarden (6919745)

Longitudinal association of muscle strength with course of mobility. by Jesse J. Aarden (6919745)

Course of mobility from admission up to three months post-discharge. by Jesse J. Aarden (6919745)

PKCλ KD leads to decreases in CD133-positive cells. by Yuka Nozaki (9115620)

California ecoregion specific total annual burned area for 2003–2020 based on MODIS MCD64A1 approximate date-of-burn product. by David E. Rother (14053316)

DNA damage induces a pan-nuclear decrease in GFP-lamin A mobility. by Robert Mahen (409641)

Linear mixed model results: Effect of bar height and approach stride number on kinetics at take-off to a jump in agility dogs. by Leena Inkilä (20614460)

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

Table_1_Loss of function of VdDrs2, a P4-ATPase, impairs the toxin secretion and microsclerotia formation, and decreases the pathogenicity of Verticillium dahliae.DOCX by Hui Ren (122548)

“…Among the mutants, the greatest decrease in pathogenicity was observed in ΔVdDrs2. …”

Analysis of <i>ATP1A1</i> (12T-ins/del) variants based on blood pressure as a quantitative trait. by Victoria L. Herrera (383897)

Subjects:

Identification of the 12T-ins/del polymorphism in the <i>ATP1A1</i> promoter region and transcriptional activity of <i>ATP1A1</i> promoter variants. by Victoria L. Herrera (383897)

Subjects:

Analysis of ATP1A1 protein expression, blood pressure, heart rate and activity in heterozygous <i>ATP1A1^+/−</i> and wild-type male mice. by Victoria L. Herrera (383897)

Subjects:

Characteristics of the study population. by Victoria L. Herrera (383897)

Subjects:

CsA reduces Flk1 protein expression and significantly decreases the percentages of Flk1+ cells. by Seung-Cheol Choi (686982)

“…(C) Representative flow cytometry profiles showing the decreased percentages of Flk1+ cells in P19 cells treated with 0.32 μM CsA during EB formation for 48 and 96 h, respectively. …”

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Illustration of the linear setup of a canine cell-free hemoglobin (cfHb) solution processed by hemoperfusion using the Cytosorb^® adsorber. by Kathrin Spiegel (21799784)